An 8-week Open-label Study of an Accelerated and Slower Switching to Xanomeline/Trospium Following Atypical Antipsychotic Treatment in Participants With Schizophrenia
An 8-week Open-label Study of an Accelerated and Slower Switching to Xanomeline/Trospium Following Atypical Antipsychotic Treatment in Participants With Schizophrenia
Not yet recruiting · NCT06924255 · Registry updated 2025-04-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An 8-week Open-label Study of an Accelerated and Slower Switching to Xanomeline/Trospium Following Atypical Antipsychotic Treatment in Participants With Schizophrenia | Schizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder, schizophrenia | Not yet recruiting | Phase 4 | 2025-04-11 | NCT06924255 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bristol-Myers Squibb | 422 |
| Collaborative Neuroscience Research, LLC | 1 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cenexel CBH | Gaithersburg | United States | 2 |
| CenExel CIT IE | Riverside | United States | 1 |
| CenExel CIT LA | Bellflower | United States | 1 |
| CenExel CNS - Garden Grove | Garden Grove | United States | 2 |
| CenExel CNS - Torrance | Torrance | United States | 1 |
| CenExel HRI Marlton | Marlton | United States | 1 |
| Cenexel RCA | Hollywood | United States | 2 |